Piramal Phytocare informs about revised financial results

04 Nov 2019 Evaluate

Piramal Phytocare has informed that in reference to the letter dated 4th November, 2019 it had enclosed the Unaudited Financial Results for the quarter and half year ended 30th September, 2019 together with the Limited Review Report by the Auditors. In the Statement of Assets and Liabilities as on 30th September, 2019, the figures for the half year ended 30th September, 2019 were inadvertently mentioned as audited instead of unaudited. In this regard, it has enclosed the Revised Unaudited Financial Results for the quarter and half year ended 30th September, 2019; and Limited Review Report by the Auditors.

The above information is a part of company’s filings submitted to BSE.

Piramal Phyt-Amalga Share Price

22.55 0.00 (0.00%)
10-Dec-2019 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.